Chemists showcase power of pathbreaking method to make complex molecules
Chemists have synthesized a highly complex natural molecule through a new strategy of functionalizing normally inert ...
manilatimes3d
Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...